Intellia Therapeutics
NTLA
NTLA
347 hedge funds and large institutions have $4.69B invested in Intellia Therapeutics in 2022 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 96 increasing their positions, 124 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
347
Holders Change
-23
Holders Change %
-6.22%
% of All Funds
5.49%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
61
Increased
96
Reduced
124
Closed
77
Calls
$44.3M
Puts
$51.9M
Net Calls
-$7.63M
Net Calls Change
+$9.61M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$77.3M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$64.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$40.4M |
| 4 |
Millennium Management
New York
|
+$35.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$28.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.7M |
| 2 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$71.6M |
| 3 |
Jennison Associates
New York
|
-$52.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$42.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$39.7M |
